IKZF1 somatic variants are part of most oncological gene panels and a risk factor for poor outcome in hematological malignancies, mostly B-ALL (including pediatric B-cell precursor ALL) and entail more intense treatment protocols. Here, IKZF1 is linked to acute lymphoblastic leukemia.